Aug. 15 (Bloomberg) -- Paul Chew, chief science officer for Sanofi Aventis USA, talks about the company's Auvi-Q injection system for the emergency treatment of life-threatening allergic reactions.
Auvi-Q is the first and only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers through the injection process. Chew speaks with Dominic Chu on Bloomberg Television's "Bottom Line." Mark Crumpton also speaks. (Source: Bloomberg)